S&P 500   4,691.92 (+0.11%)
DOW   35,672.06 (-0.13%)
QQQ   399.07 (+0.31%)
AAPL   174.56 (+1.97%)
MSFT   332.70 (-0.66%)
FB   331.09 (+2.56%)
GOOGL   2,945.59 (+0.01%)
AMZN   3,530.00 (+0.19%)
TSLA   1,063.50 (+1.12%)
NVDA   320.03 (-1.31%)
BABA   126.36 (+0.65%)
NIO   35.06 (+5.86%)
CGC   11.13 (+4.61%)
AMD   144.95 (+0.07%)
GE   98.59 (+1.07%)
MU   86.01 (+0.21%)
T   23.21 (+0.56%)
F   19.91 (-0.25%)
DIS   153.35 (+1.68%)
PFE   51.29 (-0.83%)
AMC   33.00 (+6.31%)
ACB   6.71 (+5.17%)
BA   211.72 (+1.38%)
S&P 500   4,691.92 (+0.11%)
DOW   35,672.06 (-0.13%)
QQQ   399.07 (+0.31%)
AAPL   174.56 (+1.97%)
MSFT   332.70 (-0.66%)
FB   331.09 (+2.56%)
GOOGL   2,945.59 (+0.01%)
AMZN   3,530.00 (+0.19%)
TSLA   1,063.50 (+1.12%)
NVDA   320.03 (-1.31%)
BABA   126.36 (+0.65%)
NIO   35.06 (+5.86%)
CGC   11.13 (+4.61%)
AMD   144.95 (+0.07%)
GE   98.59 (+1.07%)
MU   86.01 (+0.21%)
T   23.21 (+0.56%)
F   19.91 (-0.25%)
DIS   153.35 (+1.68%)
PFE   51.29 (-0.83%)
AMC   33.00 (+6.31%)
ACB   6.71 (+5.17%)
BA   211.72 (+1.38%)
S&P 500   4,691.92 (+0.11%)
DOW   35,672.06 (-0.13%)
QQQ   399.07 (+0.31%)
AAPL   174.56 (+1.97%)
MSFT   332.70 (-0.66%)
FB   331.09 (+2.56%)
GOOGL   2,945.59 (+0.01%)
AMZN   3,530.00 (+0.19%)
TSLA   1,063.50 (+1.12%)
NVDA   320.03 (-1.31%)
BABA   126.36 (+0.65%)
NIO   35.06 (+5.86%)
CGC   11.13 (+4.61%)
AMD   144.95 (+0.07%)
GE   98.59 (+1.07%)
MU   86.01 (+0.21%)
T   23.21 (+0.56%)
F   19.91 (-0.25%)
DIS   153.35 (+1.68%)
PFE   51.29 (-0.83%)
AMC   33.00 (+6.31%)
ACB   6.71 (+5.17%)
BA   211.72 (+1.38%)
S&P 500   4,691.92 (+0.11%)
DOW   35,672.06 (-0.13%)
QQQ   399.07 (+0.31%)
AAPL   174.56 (+1.97%)
MSFT   332.70 (-0.66%)
FB   331.09 (+2.56%)
GOOGL   2,945.59 (+0.01%)
AMZN   3,530.00 (+0.19%)
TSLA   1,063.50 (+1.12%)
NVDA   320.03 (-1.31%)
BABA   126.36 (+0.65%)
NIO   35.06 (+5.86%)
CGC   11.13 (+4.61%)
AMD   144.95 (+0.07%)
GE   98.59 (+1.07%)
MU   86.01 (+0.21%)
T   23.21 (+0.56%)
F   19.91 (-0.25%)
DIS   153.35 (+1.68%)
PFE   51.29 (-0.83%)
AMC   33.00 (+6.31%)
ACB   6.71 (+5.17%)
BA   211.72 (+1.38%)

Best Stocks Under $1.00 for 2021

The stock market has had an incredible bull-run since the Great Recession of 2008 and 2009. Stocks continue to hit new all-time highs and the price-to-earnings ratios of most S&P 500 companies look very expensive. Many investors are having trouble finding low-priced stocks that haven't already appreciated greatly during the last decade. It's hard to find a good deal on Wall Street right now when even small S&P 500 companies are trading at market caps above $1 billion.

Stocks have gotten expensive both in-terms of share price and their valuation relative to earnings. In more normal markets, a typical S&P 500 company has traded at about fifteen times their earnings. Most stocks are currently trading closer to 25 times their annual earnings. While the stock market has become more expensive as a whole, there are still a handful of undervalued stocks that are trading at less than $1.00 per share.

Value investing opportunities do exist if you're looking in the right places. Putting together a list of the best stocks under $1.00 requires investors to look at smaller and riskier companies and in sectors that are either undiscovered or unloved by the market as a whole. Some of these cheap stocks may not look especially attractive today, but long-term investors will profit if they are willing to exercise patience and hold on to shares of these comapnies through multiple economic cycles.

Some of these companies are solid investing ideas because they are too little and considered too risky to attract the interest of most managed mutual funds and Wall Street money managers. Others operate in unloved and untested areas of the market. You may find even find crypto stocks, marijuana stocks and bitcoin stocks on this list. Others have been beat up by Mr. Market after a long period of slowing profits, but are now actively trying to turn around their business and bounce back. These low-priced stocks operate in a lot of different industries, but these picks all carry two common characteristics. They all have a super-low share price of $1.00 or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.


Tidewater Midstream and Infrastructure logo

#1 - Tidewater Midstream and Infrastructure

OTCMKTS:TWMIF
Stock Price: $0.99 (+$0.05)
Average Trading Volume: 15,454 shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $1.81 (83.0% Upside)
Tidewater Midstream & Infrastructure Ltd. engages in the acquisition and development of oil and gas infrastructure, including gas plants, pipelines, NGLs by rail, export terminals and storage facilities. The company also engages in purchasing, selling and transportation of natural gas liquids throughout North America and export to overseas markets. Its midstream and infrastructure activities include gathering, processing and transportation, marketing and extraction of natural gas and NGL. Tidewater Midstream & Infrastructure was founded by Tobias J. McKenna on February 4, 2015 and is headquartered in Calgary, Canada.
Quisitive Technology Solutions logo

#2 - Quisitive Technology Solutions

OTCMKTS:QUISF
Stock Price: $0.75 (+$0.04)
Average Trading Volume: 40,361 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.30 (206.0% Upside)
Quisitive Technology Solutions, Inc. is a full-service digital technology consulting company, which acquire and integrate companies to become the provider of Microsoft professional services in North America. Its solutions include application development, business applications, data and analytics, digital transformation, digital workplace, and infrastructure. The firm also offers payment products and services. The company is founded by Michael Reinhart on August 12, 2011 and is headquartered in Toronto, Canada.
CohBar logo

#3 - CohBar

NASDAQ:CWBR
Stock Price: $0.50 (+$0.00)
PE Ratio: -1.78
Market Cap: $42.86 million
Average Trading Volume: 1.70 million shares
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $3.75 (653.0% Upside)
CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA.
Marrone Bio Innovations logo

#4 - Marrone Bio Innovations

NASDAQ:MBII
Stock Price: $0.73 (+$0.04)
PE Ratio: -7.29
Market Cap: $129.09 million
Average Trading Volume: 573,269 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.90 (298.0% Upside)
Marrone Bio Innovations, Inc. engages in the provision of Biological based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. Its products include Grandevo Insecticide, Majestene Nematicide, Regalia Fungicide, Stargus Fungicide, Venerate Insecticide, Amplitude Fungicide, Regalia Rx Plant Health, Zelto Nematicide, Zequanox Molluscicide and Haven. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Davis, CA.
9 Meters Biopharma logo

#5 - 9 Meters Biopharma

NASDAQ:NMTR
Stock Price: $0.96 (-$0.01)
Market Cap: $245.42 million
Average Trading Volume: 5.38 million shares
Consensus Rating: Buy (7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $5.00 (420.9% Upside)
9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
Stagecoach Group logo

#6 - Stagecoach Group

OTCMKTS:SAGKF
Stock Price: $0.96
Market Cap: $550.41 million
Average Trading Volume: 350 shares
Consensus Rating: Buy (6 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A
Stagecoach Group plc, together with its subsidiaries, provides public transportation services in the United Kingdom. It operates through three segments: UK Bus (Regional Operations), UK Bus (London), and UK Rail. The company offers bus, coach, rail, and tram services. It operates city buses primarily in Liverpool, Newcastle, Hull, Manchester, Oxford, Sheffield, Cambridge, and Exeter through a fleet of approximately 7,100 buses and coaches; inter-urban services linking major towns within its regional operating areas, as well as megabus.com, an inter-city coach service; and buses from 10 depots with a fleet of approximately 1,150 buses serving routes in and around east and south-east London. The company also operates Sheffield Supertram, a 28 km light rail network with three routes in the city of Sheffield. It serves individuals, local authorities, transport authorities, and the United Kingdom department for transport. The company was founded in 1980 and is headquartered in Perth, the United Kingdom.
Surgalign logo

#7 - Surgalign

NASDAQ:SRGA
Stock Price: $0.78 (+$0.01)
PE Ratio: -0.48
Market Cap: $109.16 million
Average Trading Volume: 2.87 million shares
Consensus Rating: Buy (4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $3.15 (301.7% Upside)
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. Its products portfolio include cervical fixation, The Streamline (TL) fixation, motion preservation, orthobiologics, cervical inter-body fusion, TL IBF, and SI joint fusion. It offers coflex interlaminar stabilization device, SImmetry sacroiliac joint fusion system, and Fortilink IBF system with TETRAfuse?3D technology. The company was founded on February 12, 1998 and is headquartered in Deerfield, IL.
Antibe Therapeutics logo

#8 - Antibe Therapeutics

OTCMKTS:ATBPF
Stock Price: $0.54 (-$0.02)
PE Ratio: -1.13
Market Cap: $28.21 million
Average Trading Volume: 42,677 shares
Consensus Rating: Buy (4 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $4.50 (726.3% Upside)
Antibe Therapeutics, Inc. is a biotechnology company, which engages in the development of medicines for pain and inflammation. It operates through the Antibe Therapeutics and Citagenix segments. The Antibe Therapeutics segment focuses on the development of pharmaceutical products. The Citagenix segment involves in the development and sale of regenerative medicines serving the dental and orthopedic market places. The company was founded by Andre Buret, John Wallace, and Giuseppe Cirino on May 5, 2009 and is headquartered in Toronto, Canada.
Americas Silver logo

#9 - Americas Silver

NYSEAMERICAN:USAS
Stock Price: $0.80 (+$0.02)
PE Ratio: -0.76
Market Cap: $125.35 million
Average Trading Volume: 1.20 million shares
Consensus Rating: Buy (3 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.04 (155.2% Upside)
Americas Gold and Silver Corporation engages in the acquisition, evaluation, exploration, development, and operation of mineral properties. The company explores for silver, lead, zinc and copper. It principally owns 100% interests in the Cosalá Operations consisting of 67 mining concessions that cover approximately 19,385 hectares located in the state of Sinaloa, Mexico; and Galena Complex situated near the town of Wallace in the state of Idaho, the United States. The company was formerly known as Americas Silver Corporation and changed its name to Americas Gold and Silver Corporation in September 2019. Americas Gold and Silver Corporation was incorporated in 1998 and is headquartered in Toronto, Canada.
MGM China logo

#10 - MGM China

OTCMKTS:MCHVF
Stock Price: $0.66 (+$0.01)
Average Trading Volume: 9,350 shares
Consensus Rating: Hold (2 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A
MGM China Holdings Limited, an investment holding company, engages in the development, ownership, and operation of gaming and lodging resorts in the Greater China region. The company develops and operates casino games of chance and other casino games, and related hotel and resort facilities, as well as provides hotel management services; and develops integrated resorts in Macau. It owns and operates MGM Macau, an integrated resort that includes a casino with 638 slot machines and 279 gaming tables; a hotel with 582 hotel rooms, suites, and villas; and amenities, including eight restaurants, retail outlets, pool, and spa facilities, as well as a convention space. The company also owns MGM Cotai, a resort that consists of a casino with 655 slot machines and 273 gaming tables; a hotel with 1,390 hotel rooms, suites, and skylofts; twelve restaurants and bars; retail outlets; and a meeting space, as well as other non-gaming offerings. In addition, MGM China Holdings Limited is involved in the provision of outsourcing services, including information technology, accounting, human resources, hotel reservation, and convention consultation. The company was incorporated in 2010 and is headquartered in Macau. MGM China Holdings Limited is a subsidiary of MGM Resorts International.
CaixaBank logo

#11 - CaixaBank

OTCMKTS:CAIXY
Stock Price: $0.87 (+$0.01)
Average Trading Volume: 242,944 shares
Consensus Rating: Hold (3 Buy Ratings, 6 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A
CaixaBank SA is an integrated financial group, which provides banking and insurance services. The firm offers banking business, insurance, pension and investment fund activities, as well as holdings in international banks. It operates through the following segments: Banking & Insurance, Equity Investments, and BPI. The Banking & Insurance segment core business includes the entire banking business, including retail banking, corporate banking, cash and markets, and the insurance business, primarily carried out in Spain through the branch network and the other complementary channels. It also offers life insurance, pension plans and general insurance products. The Equity Investment segment engages in the equity investment business. The BPI segment comprises all businesses under BPI group. The company was founded on December 12, 1980 and is headquartered in Valencia, Spain.
Petrofac logo

#12 - Petrofac

OTCMKTS:POFCY
Stock Price: $0.73
Market Cap: $763.61 million
Average Trading Volume: 13,420 shares
Consensus Rating: Hold (3 Buy Ratings, 6 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A
Petrofac Ltd. engages in the provision of services to the oil and gas production and processing industry. It offers engineering and construction; operations and maintenance; and training and competence. The firm operates through the following segments: Engineering and Construction; Engineering and Production Services; and Integrated Energy Services. The Engineering and Construction segment provides fixed-price engineering, procurement and construction project execution services and reimbursable engineering, procurement and construction management services to the onshore and offshore oil and gas industry. The Engineering and Production Services segment includes reimbursable engineering and production services activities to the oil and gas industry. The Integrated Energy Services segment focuses on delivering value from the existing asset portfolio. The company was founded in 1981 and is headquartered in St. Helier, the United Kingdom.
Tullow Oil logo

#13 - Tullow Oil

OTCMKTS:TUWOY
Stock Price: $0.27 (+$0.03)
Market Cap: $772.66 million
Average Trading Volume: 41,701 shares
Consensus Rating: Hold (3 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings)
Consensus Price Target: N/A
Tullow Oil Plc engages in the exploration, development and production of oil and gas. It operates through the following geographical segments: West Africa, East Africa, and New Ventures. The company was founded by Aidan Joseph Heavey in 1985 and is headquartered in London, the United Kingdom.
Idera Pharmaceuticals logo

#14 - Idera Pharmaceuticals

NASDAQ:IDRA
Stock Price: $0.78 (+$0.15)
PE Ratio: -0.31
Market Cap: $41.12 million
Average Trading Volume: 1.76 million shares
Consensus Rating: Hold (0 Buy Ratings, 5 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $1.50 (92.6% Upside)
Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.
Cineworld Group logo

#15 - Cineworld Group

OTCMKTS:CNNWF
Stock Price: $0.68
Average Trading Volume: 95,460 shares
Consensus Rating: Hold (1 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings)
Consensus Price Target: N/A
Cineworld Group plc engages in the cinema business. It is also involved in financing, retail, cinema property leasing, property, ticket booking, film distribution, advertising, general partner, and gift promotion activities. The company operates its cinema sites under the Regal, United Artists, Edwards theatres, Cineworld, Picturehouse, Cinema City, Yes Planet, and Rav-Chen brands. As of December 31, 2020, it operated 9,311 screens in 767 sites in the United States, the United Kingdom, Ireland, Poland, Israel, Hungary, Romania, the Czech Republic, Bulgaria, and Slovakia. The company was founded in 1995 and is headquartered in Brentford, the United Kingdom.
Ceconomy logo

#16 - Ceconomy

OTCMKTS:MTTRY
Stock Price: $0.77 (+$0.02)
Market Cap: $1.38 billion
Average Trading Volume: 6,554 shares
Consensus Rating: Hold (2 Buy Ratings, 1 Hold Ratings, 4 Sell Ratings)
Consensus Price Target: N/A
CECONOMY AG engages in the provision of online platform technology solutions to the consumer electronics industry. Its brands include MediaMarkt, Saturn, iBood, and Juke. It operates through the following geographical segments: DACH (Germany, Austria, Switzerland, Hungary), Western and Southern Europe, Eastern Europe, and Others. The company is headquartered in Dusseldorf, Germany.
DiaSorin logo

#17 - DiaSorin

OTCMKTS:DSRLF
Stock Price: $0.01
Market Cap: $662,000.00
Average Trading Volume: 151 shares
Consensus Rating: Hold (1 Buy Ratings, 3 Hold Ratings, 2 Sell Ratings)
Consensus Price Target: $201.25 (1,663,123.1% Upside)
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics. It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis & retrovirus, oncology and endocrinology. The company was founded in 1968 and is headquartered in Vercelli, Italy.
Sundial Growers logo

#18 - Sundial Growers

NASDAQ:SNDL
Stock Price: $0.63 (+$0.03)
PE Ratio: -3.48
Market Cap: $1.04 billion
Average Trading Volume: 243.72 million shares
Consensus Rating: Hold (0 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings)
Consensus Price Target: $0.73 (17.1% Upside)
Sundial Growers, Inc. engages in the production and distribution of flower, pre-rolls and vapes. The firm offers licensed producer, ACMPR, cannabis, medical cannabis, health and wellness, and cannabis extracts. The company was founded by Stanley J. Swiatek and is headquartered in Calgary, Canada.
Banco de Sabadell logo

#19 - Banco de Sabadell

OTCMKTS:BNDSF
Stock Price: $0.66 (-$0.01)
Average Trading Volume: 16,794 shares
Consensus Rating: Hold (0 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings)
Consensus Price Target: N/A
Banco de Sabadell SA engages in the provision of banking and financial services. It operates through the following segments: Business Banking in Spain, Asset Transformation, Banking Business in the United Kingdom, and Banking Business in America. The Business Banking in Spain segment encompasses covers commercial banking, corporate banking, and markets and private banking. The Asset Transformation segment comprehensively manages abnormal risk and real estate exposure, and also sets out and implements the strategy of real estate investees, such as Solvia. The Banking Business in the United Kingdom segment corresponds to TSB Banking Group PLC which offers current and savings accounts, personal loans, cards, and mortgages. The Banking Business in America segment is made up of a number of business units, affiliates, and representative offices that engage in corporate baking, private banking, and commercial banking activities related to finance. The company was founded on December 31, 1881 and is headquartered in Alicante, Spain.
Hammerson logo

#20 - Hammerson

OTCMKTS:HMSNF
Stock Price: $0.42
Market Cap: $63.65 million
Average Trading Volume: 140,855 shares
Consensus Rating: Hold (1 Buy Ratings, 3 Hold Ratings, 6 Sell Ratings)
Consensus Price Target: N/A
Hammerson Plc engages in the investment, development, and management of shopping centers, retail parks, and offices. It operates through the following geographical segments: United Kingdom, France, and Ireland. The United Kingdom segment consists of shopping centers, retail parks, and other. The France segment involves in the development activities. The Ireland segment includes shopping centers. The company was founded by Lewis W. Hammerson in 1942 and is headquartered in London, the United Kingdom.

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.